2.4k total citations 13 papers, 197 citations indexed
About
Tormey Dc is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Tormey Dc has authored 13 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tormey Dc's work include Cancer Treatment and Pharmacology (6 papers), Advanced Breast Cancer Therapies (3 papers) and Breast Cancer Treatment Studies (3 papers). Tormey Dc is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Advanced Breast Cancer Therapies (3 papers) and Breast Cancer Treatment Studies (3 papers). Tormey Dc collaborates with scholars based in United States. Tormey Dc's co-authors include Holland Jf, R Gray, Matthew Knuiman, Geoffrey Falkson, Jakob Blom, Clark Gm, McGuire Wl, J Y Djeu, Oldham Rk and West Wh and has published in prestigious journals such as PubMed.
In The Last Decade
Tormey Dc
13 papers
receiving
182 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Tormey Dc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tormey Dc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tormey Dc more than expected).
This network shows the impact of papers produced by Tormey Dc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tormey Dc. The network helps show where Tormey Dc may publish in the future.
Co-authorship network of co-authors of Tormey Dc
This figure shows the co-authorship network connecting the top 25 collaborators of Tormey Dc.
A scholar is included among the top collaborators of Tormey Dc based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Tormey Dc. Tormey Dc is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
13 of 13 papers shown
1.
Dc, Tormey, et al.. (1992). Chemotherapy versus observation in high-risk node-negative breast cancer patients.. PubMed. 97–104.5 indexed citations
2.
Gray, R, et al.. (1992). Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076).. PubMed. 167–72.16 indexed citations
3.
Dc, Tormey, et al.. (1986). Postoperative chemotherapy and chemohormonal therapy in women with node-positive breast cancer.. PubMed. 75–80.34 indexed citations
4.
Falkson, Geoffrey, et al.. (1985). Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancer.. PubMed. 69(7-8). 755–60.3 indexed citations
5.
Gelman, R. S., et al.. (1981). Adriamycin plus vincristine alone or with dibromodulcitol or ICRF-159 in metastatic breast cancer.. PubMed. 4(3). 253–60.7 indexed citations
6.
Dc, Tormey, et al.. (1981). Venous thrombosis during multimodal treatment of primary breast carcinoma.. PubMed. 65(7-8). 677–9.94 indexed citations
7.
Chang, Yeun‐Chung, Geoffrey Falkson, Tormey Dc, & John Crowley. (1981). Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.. PubMed. 4(4). 377–80.1 indexed citations
8.
Dc, Tormey, et al.. (1981). Vindesine. A phase II trial in advanced breast cancer patients.. PubMed. 4(4). 371–5.7 indexed citations
9.
Dc, Tormey, et al.. (1980). L-phenylalanine mustard, doxorubicin, and vincristine in advanced breast cancer: a pilot study.. PubMed. 64(8-9). 1015–6.2 indexed citations
10.
Dc, Tormey, et al.. (1980). Biological markers as prognostic and clinical evaluation tools.. PubMed. Suppl 1. 21–4.3 indexed citations
11.
Dc, Tormey, et al.. (1980). Phase II trial of 6-thioguanine in metastatic breast cancer.. PubMed. 64(1). 191–2.3 indexed citations
12.
Rk, Oldham, Tormey Dc, Cohen Mh, et al.. (1977). Immunologic monitoring in carcinoma of the breast.. PubMed. 145(2). 209–18.15 indexed citations
13.
Dc, Tormey, et al.. (1973). Clinical evaluation of hexamethylmelamine (NSC-13875).. PubMed. 57(1). 51–8.7 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.